Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
4-6 minutes (native TRH); analog taltirelin has extended duration
Delivery
Subcutaneous or intravenous injection; oral administration for stable analogs like taltirelin
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Thyrotropin-Releasing Hormone (TRH) is a tripeptide hormone naturally produced in the hypothalamus that regulates thyroid function by stimulating the release of thyroid-stimulating hormone (TSH) from the pituitary gland. Beyond its endocrine role, TRH exhibits neuroprotective properties and influences energy metabolism, neural oscillations, and cognitive function. Research has demonstrated its potential therapeutic applications in neurodegenerative conditions, PTSD-like symptoms, and metabolic regulation.
TRH analogs such as taltirelin are used in research settings, typically administered at doses ranging from 0.5-2 mg orally or via injection. Research protocols vary based on application, with some studies examining single-dose effects while others investigate chronic administration. Timing is often coordinated with circadian rhythms due to TRH's role in hypothalamic-pituitary axis regulation.
TRH binds to TRH receptors (TRHR1 and TRHR2) in the pituitary gland, triggering TSH release which subsequently stimulates thyroid hormone production. In the central nervous system, TRH activates the phosphatidylinositol 3-kinase/AKT pathway, promoting neuroprotection and new protein synthesis. TRH neurons in the paraventricular nucleus regulate branched-chain amino acid catabolism, influencing energy expenditure. The peptide also modulates neural oscillations and protects against glutamate excitotoxicity in hippocampal neurons.